| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 45.090 | 38.507 | 47.777 | 58.553 | 60.925 | 68.469 | 79.284 | 94.456 | 98.383 | 108.917 |
| Total Income - EUR | 45.128 | 38.895 | 47.908 | 58.942 | 61.261 | 68.517 | 79.387 | 94.670 | 98.424 | 117.353 |
| Total Expenses - EUR | 30.939 | 30.045 | 30.867 | 39.015 | 41.948 | 41.419 | 31.530 | 42.217 | 51.923 | 56.601 |
| Gross Profit/Loss - EUR | 14.189 | 8.851 | 17.041 | 19.927 | 19.313 | 27.098 | 47.857 | 52.453 | 46.501 | 60.752 |
| Net Profit/Loss - EUR | 13.737 | 8.459 | 16.563 | 19.432 | 18.741 | 26.412 | 47.063 | 51.507 | 43.902 | 57.829 |
| Employees | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Dobrimed Srl
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 40.439 | 35.078 | 30.338 | 24.433 | 18.770 | 15.049 | 14.215 | 13.323 | 12.404 | 78.938 |
| Current Assets | 28.827 | 22.252 | 22.133 | 11.214 | 12.494 | 17.816 | 56.303 | 45.308 | 39.060 | 53.215 |
| Inventories | 3.717 | 3.347 | 3.584 | 3.709 | 3.816 | 3.191 | 2.966 | 2.699 | 539 | 532 |
| Receivables | 5.982 | 4.037 | 4.427 | 5.834 | 5.748 | 5.762 | 37.034 | 13.456 | 716 | 41.078 |
| Cash | 19.128 | 10.472 | 8.391 | 1.671 | 1.871 | 3.941 | 11.263 | 23.916 | 37.805 | 11.605 |
| Shareholders Funds | 61.472 | 55.757 | 50.013 | 23.158 | 22.396 | 29.987 | 50.648 | 55.081 | 47.457 | 61.413 |
| Social Capital | 2.626 | 2.582 | 2.534 | 42 | 41 | 40 | 41 | 40 | 40 | 40 |
| Debts | 7.794 | 1.573 | 2.458 | 12.488 | 8.868 | 2.879 | 19.869 | 3.550 | 4.007 | 3.888 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 66.852 |
| Exchange rate - RON | 5.0415 | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Dobrimed Srl